Associate Professor Mark Smythe ... his research led to new biotech company

University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.

22 August 2016
Professor Robert Parton, from the Institute for Molecular Bioscience, is leading a $7.1 million research project to study the mechanisms behind healthy cells transforming into cancerous cells.

Cutting-edge research that aims to stop the transformation of healthy cells into cancerous cells is one of nine prestigious grants and scholarships awarded to health and medical researchers at The University of Queensland (UQ).

15 December 2011